Human CTLA-4 (Research Grade Ipilimumab Biosimilar) Alexa Fluor 405-conjugated Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FAB9928V100-Each-of-1 | In Stock | ₹ 43,699.00 |
FAB9928V100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,699.00
GST (18%): ₹ 7,865.82
Total Price: ₹ 51,564.82
Antigen
CTLA-4
Classification
Monoclonal
Conjugate
Alexa Fluor 405
Formulation
Supplied 0.2 mg/ml in a saline solution containing BSA and Sodium Azide.
Host Species
Human
Purification Method
Protein A or G purified from cell culture supernatant
Primary or Secondary
Primary
Test Specificity
Detects Human CTLA-4 based on Ipilimumab therapeutic antibody.This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. This product is for research use only.
Content And Storage
Protect from light.Do not freeze.12 months from date of receipt, 2 to 8 degreesC as supplied.
Isotype
IgG1
Applications
Flow Cytometry
Clone
Hu111
Dilution
Flow Cytometry 0.25-1 μg/10^6 cells
Gene Alias
CD, CD152, CD152 antigen, CD152IDDM12, CD28, celiac disease 3, CELIAC3, CTLA4, CTLA-4, cytotoxic T-lymphocyte antigen 4, cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, cytotoxic T-lymphocyte-associated protein 4, cytotoxic T-lymphocyte-associated serine esterase-4, GRD4, GSE, ICOS, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
Immunogen
Human CTLA-4
Quantity
100 μg
Gene ID (Entrez)
1493
Target Species
Human
Form
Supernatant
Related Products
Description
- CTLA-4 Monoclonal specifically detects CTLA-4 in Human samples
- It is validated for Flow Cytometry.